Literature DB >> 11716653

Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer?

A Fry1, R Rush, C Busby-Earle, A Cull.   

Abstract

BACKGROUND: Little is known about the factors that women at increased risk of ovarian cancer consider to be important when deciding about prophylactic oophorectomy, surgery to remove the ovaries before they develop cancer.
METHODS: Women who had undergone prophylactic oophorectomy (surgical group; n = 30) were compared with women who remained on the ovarian screening program (nonsurgical group; n = 28) on their importance ratings for a number of relevant decision-making factors.
RESULTS: The most important decision-making factor across all subjects was reducing risk of ovarian cancer, but the single best predictor of group membership was the importance attributed to reducing cancer worry. Women who rated this factor as more important were more likely to be in the surgical group. No women identified the increased risk of heart disease and osteoporosis as issues for consideration.
CONCLUSIONS: The desire to reduce cancer worry is likely to be the most important factor in a woman's decision to proceed to prophylactic oophorectomy. In view of the current imprecision in risk estimates given to women considering this option, cancer worry may override a more rational consideration of the costs and benefits of surgery. Copyright 2001 American Health Foundation and Elsevier Science.

Entities:  

Mesh:

Year:  2001        PMID: 11716653     DOI: 10.1006/pmed.2001.0924

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

2.  Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

Authors:  Mary Kathleen Ladd; Beth N Peshkin; Leigha Senter; Shari Baldinger; Claudine Isaacs; Hannah Segal; Samantha Philip; Chloe Phillips; Kate Shane; Aimee Martin; Veronique Weinstein; Robert Pilarski; Joanne Jeter; Kevin Sweet; Bonnie Hatten; Elisabeth J Wurtmann; Shanda Phippen; Della Bro; Marc D Schwartz
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

3.  The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.

Authors:  Kelly A Metcalfe; Carrie Snyder; Jennifer Seidel; Danielle Hanna; Henry T Lynch; Steven Narod
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff; Patricia Rodney
Journal:  Qual Health Res       Date:  2010-10-27

5.  Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

Authors:  Kate J Lifford; Alison Clements; Lindsay Fraser; Deborah Lancastle; Kate Brain
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

6.  What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.

Authors:  Danielle Campfield Bonadies; Anne Moyer; Ellen T Matloff
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

7.  Risk-reduction surgery decisions in high-risk women seen for genetic counseling.

Authors:  Jessica A Ray; Lois J Loescher; Molly Brewer
Journal:  J Genet Couns       Date:  2005-12       Impact factor: 2.537

Review 8.  New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.

Authors:  Suzanne M Miller; Pagona Roussi; Mary B Daly; John Scarpato
Journal:  Clin Cancer Res       Date:  2010-09-09       Impact factor: 12.531

9.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 10.  Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review.

Authors:  A Fuchsia Howard; Lynda G Balneaves; Joan L Bottorff
Journal:  J Genet Couns       Date:  2009-10-03       Impact factor: 2.537

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.